ProPharma helped accelerate BLA readiness and scalable commercialization for cell therapies.
Public source
Publisher name
Public post
Commercializing cell therapies requires aligned quality, regulatory, and manufacturing strategies. See how ProPharma helped accelerate BLA readiness and scalable commerc…
Company
ProPharma
End-to-end bespoke solutions that de-risk & accelerate our partners' and sponsors' drug and device development programs
- Industry
- Business Consulting and Services
- Location
- Raleigh, US
- Company size
- 1,001–5,000 employees
About ProPharma
At ProPharma, we help pharmaceutical, biotechnology, and medical device companies bring life-changing therapies to market. From early development through clinical, regulatory approval, and commercialization, we provide expert guidance to navigate complex challenges and accelerate success. Our mission is simple: improving patient health and safety by delivering the highest-quality regulatory, compliance, clinical research, pharmacovigilance, and medical information services throughout the entire product lifecycle. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the complete product lifecycle through an advise-build-operate model. Our end-to-end suite of consulting solutions de-risks and accelerates high-profile drug and device programs, ultimately improving patient health and safety. Discover how ProPharma can help you inspire the future of science!
See moreLatest activity
Latest activity from ProPharma
18 signals
Presence & Recognition
ProPharma Senior Director, Pharmacovigilance Case Processing, Keith Parrell discusses how strong safety databases, workflow automation, and cross-functional collaboration help manage adverse event cases, maintain data quality, support inspection readiness, and protect patient safety.
Presence & Recognition
ProPharma team will be attending Lab of the Future Europe in Amsterdam from September 22 to 23, 2026.
Presence & Recognition
ProPharma employee Eva Zaccariotto attended a presentation by Esra Guven at KENX in Toronto on September 22 discussing intelligent systems inspection.
Discover more
Similar signals
Similar public activity from other companies.
Customers & Market
DeciBio
DeciBio notes that Zelluna cleared the first safety review in ZIMA-101, the first clinical test of a TCR-NK therapy, with no dose-limiting toxicities observed.
Customers & Market
Syner-G
Syner-G stepped in with a fractional, fully integrated CMC operating model for a biotech client over nearly three years to support licensing, tech transfer, global regulatory submissions, Phase 3 readiness, quality system buildout, CDMO oversight, and transition to an acquiring sponsor.
Customers & Market
PRP Compliance
PRP Compliance helped a medical device team accelerate FDA submission readiness and avoid a costly market delay by deploying flexible resourcing and a focused end-to-end plan.
Customers & Market
WuXi Biologics
WuXi Biologics achieved DNA-to-IND in just 6 months with a 100% PPQ campaign success rate.
Customers & Market
WEP Clinical